Silverarc Capital Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.79M Sell
179,700
-177,858
-50% -$6.58M 0.59% 40
2025
Q4
$15.1M Buy
357,558
+121,767
+52% +$4.91M 2.09% 14
2025
Q3
$8.09M Sell
235,791
-212,704
-47% -$6.1M 1.09% 31
2025
Q2
$12.1M Sell
448,495
-185,337
-29% -$5.37M 2.24% 17
2025
Q1
$18.8M Buy
633,832
+130,551
+26% +$4.98M 3.84% 7
2024
Q4
$19.9M Buy
503,281
+32,716
+7% +$1.24M 4.36% 6
2024
Q3
$16M Buy
470,565
+188,317
+67% +$5.3M 3.6% 7
2024
Q2
$6.12M Buy
282,248
+1,475
+0.5% +$31K 1.44% 23
2024
Q1
$6.22M Buy
280,773
+33,050
+13% +$806K 1.73% 22
2023
Q4
$6.81M Buy
247,723
+8,152
+3% +$197K 2.03% 17
2023
Q3
$5.35M Buy
239,571
+10,120
+4% +$260K 1.62% 26
2023
Q2
$5.84M Buy
229,451
+19,798
+9% +$480K 1.81% 18
2023
Q1
$4.68M Buy
209,653
+9,653
+5% +$233K 1.93% 21
2022
Q4
$4.75M Sell
200,000
-465,854
-70% -$10.8M 1.36% 27
2022
Q3
$11.1M Sell
665,854
-52,935
-7% -$1.19M 3.74% 4
2022
Q2
$14.3M Buy
718,789
+293,235
+69% +$5.92M 4.4% 5
2022
Q1
$11.7K Buy
425,554
+204,192
+92% +$5.84M 4.86% 5
2021
Q4
$9.12M Buy
221,362
+41,814
+23% +$1.85M 3.7% 6
2021
Q3
$8.34M Buy
179,548
+28,687
+19% +$1.25M 4.72% 2
2021
Q2
$6.03K Buy
150,861
+90,861
+151% +$3.89M 2.69% 6
2021
Q1
$3.23M Buy
+60,000
New +$3.46M 1.76% 21

Other funds holding VCYT

Silverarc Capital Management's VCYT Position: Q1 2026 in Review

Silverarc Capital Management reduced its Veracyte (VCYT) stake by 50% in Q1 2026, selling an estimated $6.58M and leaving 179,700 shares worth $5.79M. The position accounts for 0.59% of the portfolio, ranked #40.

Silverarc Capital Management first reported a position in VCYT in Q1 2021 and has held it in 21 quarters since. The position peaked at $19.9M in Q4 2024. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Silverarc Capital Management held 179,700 shares of Veracyte worth $5.79M as of Q1 2026.
  • Silverarc Capital Management sold 177,858 Veracyte shares in Q1 2026, an estimated $6.58M.
  • Veracyte made up 0.59% of Silverarc Capital Management's portfolio in Q1 2026, its #40 holding.
  • Silverarc Capital Management first reported a position in Veracyte in Q1 2021 and has held it in 21 quarters since.
  • Silverarc Capital Management's Veracyte position peaked at $19.9M in Q4 2024.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Silverarc Capital Management's 13F filing for Q1 2026, filed 14 May 2026.